-
1 Comment
Aidigong Maternal & Child Health Limited is currently in a long term uptrend where the price is trading 88.0% above its 200 day moving average.
From a valuation standpoint, the stock is 97.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.0.
Aidigong Maternal & Child Health Limited's total revenue sank by 14.6% to $324M since the same quarter in the previous year.
Its net income has increased by 142.6% to $26M since the same quarter in the previous year.
Finally, its free cash flow fell by 2562.1% to $-93M since the same quarter in the previous year.
Based on the above factors, Aidigong Maternal & Child Health Limited gets an overall score of 3/5.
Industry | Medical Care Facilities |
---|---|
Exchange | HK |
CurrencyCode | HKD |
ISIN | BMG0133U1062 |
Sector | Healthcare |
Target Price | 15.25 |
---|---|
Market Cap | 252M |
PE Ratio | None |
Beta | 0.37 |
Dividend Yield | None |
Aidigong Maternal & Child Health Limited, an investment holding company, provides postpartum care and healthcare services in the People's Republic of China. The company operates through Postpartum Care Services, Health Industry, and Other segments. It offers maternal and child healthcare services; medical anti-aging services; healthcare industry investment services; and healthcare property development services, as well as management, investment, and finance services. The company was formerly known as Common Splendor International Health Industry Group Limited and changed its name to Aidigong Maternal & Child Health Limited in December 2019. Aidigong Maternal & Child Health Limited was incorporated in 1990 and is based in Wan Chai, Hong Kong.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 0286.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025